Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2025 ,inter alia, to consider and approve Intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed the stock exchange that its Board of Directors will meet on Thursday, November 27, 2025, at the registered office. The key agenda item is to consider and approve raising additional financial resources through equity shares, convertible instruments, or other securities. The company is exploring multiple routes including preferential allotment, rights issue, Qualified Institutional Placements (QIPs), ADRs, GDRs, FCCBs, or a combination of these methods, possibly in multiple tranches. Additionally, any other matter with the Chair's permission may be taken up. The trading window for designated persons and their immediate relatives has been closed from November 24, 2025, and will remain closed until 48 hours after the Board Meeting concludes.
For shareholders, this filing signals a potential dilution event ahead as the company weighs various equity-raising options. The exact method, size, and pricing will only be known after the November 27 board meeting, which could influence short-term stock sentiment depending on the chosen route and terms.